RIGL Rigel Corp: Rasio rega marang prakiraan pendapatan
Rigel Pharmaceuticals (RIGL) focuses on bringing drugs for autoimmune and hematological pathologies to market, expanding sales of Tavalisse. The forward P/S indicator clearly demonstrates the dynamics of this strategy, where the 10.80 level represents the current value. Growth is driven by premium pricing for original therapies, as well as a strong team of experts motivated by bonuses and a high-quality benefits package.
RIGL (Rigel Corp): rincian analitis lan laporan miturut indikator
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Rigel Pharmaceuticals|RIGL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Rigel Pharmaceuticals|RIGL - Utang perusahaan|Utang marang nilai buku Rigel Corp|RIGL - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rigel Pharmaceuticals|Rasio cepet rigel.com
- rincian asil keuangan lan kelipatan valuasi:
RIGL - Bathi pungkasan|Proyeksi bathi mangsa ngarep Rigel Pharmaceuticals|RIGL - Pangali P/E|Rega marang bathi mangsa ngarep Rigel Pharmaceuticals Inc|RIGL - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rigel Corp|RIGL - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Rigel Pharmaceuticals|RIGL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan rigel.com|RIGL - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Rigel Pharmaceuticals
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:Rigel Pharmaceuticals, Inc. (RIGL)
Investors must find a balance between operational risks and the efficiency of capital returns. Stable demand for Rigel Pharmaceuticals (RIGL) hematology drugs generates a predictable cash flow. The forward P/S valuation history reflects the ratio of business value to expected annual revenue, revealing the capitalization's sensitivity to financial gaps. Current price action confirms the resilience of the model due to regular medication refills.
Pesaing wigati
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABVX - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan ADMA (ADMA Corp)|PTGX: Multiplikator Forward P/S|IMVT - Rasio kapitalisasi marang dodolan sing dikarepake|KNSA (Kiniksa) - Multiplikator Forward P/S|GRFS - Prakiraan rega marang pendapatan|Multiplikator Forward P/S ADPT|CLDX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Aurinia Pharmaceuticals AUPH|biocryst.com - Rasio rega marang prakiraan pendapatan|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ABCL (AbCellera Corp)|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|PGEN: Rega forward marang dodolan|Multiplikator Forward P/S PHAR|Multiplikator Forward P/S Nektar Therapeutics Inc (NKTR)|Rasio rega marang prakiraan pendapatan Upstream Bio Corp UPB|Rega forward marang dodolan ZBIO|IMNM - Rasio rega marang prakiraan pendapatan|gossamerbio.com (GOSS) - Multiplikator forward rega marang pendapatan|KALV: Multiplikator Forward P/S|Septerna, Inc. (SEPN) - Multiplikator Forward P/S|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Savara Pharma (SVRA)|Multiplikator Forward P/S ANAB|ATXS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|enGene - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S RAPT Therapeutics Inc. RAPT|JBIO: Multiplikator forward rega marang pendapatan|Aclaris Therapeutics, Inc - Rasio rega marang pendapatan sing dikarepake|KYTX: Multiplikator Forward P/S|TLSA - Rasio kapitalisasi marang dodolan sing dikarepake|CABA (Cabaletta Bio) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Ventyx Biosciences Inc. (VTYX)|Multiplikator Forward P/S THTX|Multiplikator Forward P/S Avalo Therapeutics Inc (AVTX)|Rasio rega marang prakiraan pendapatan Eledon Pharmaceuticals ELDN|agenusbio.com - Rasio rega marang prakiraan pendapatan|CLYM - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Zura Bio Ltd ZURA|aTyr (ATYR) - Rasio rega marang prakiraan pendapatan|Adagene Inc. - Rega forward marang dodolan|IMA (ImageneBio) - Multiplikator Forward P/S|Shattuck Therapeutics (STTK) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S EQ|connectbiopharm.com (CNTB) - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Immunic IMUX|Atara Biotherapeutics, Inc. - Rasio rega marang prakiraan pendapatan|IFRX - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan XFOR|ACET: Multiplikator Forward P/S|Celularity - Rega forward marang dodolan|INMB (INmune Bio Corp) - Multiplikator Forward P/S|Multiplikator Forward P/S Barinthus Biotherapeutics Corp|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Akari Therapeutics Plc AKTX|ENLV - Multiplikator forward rega marang pendapatan|Q32 Bio Corp - Multiplikator Forward P/S|GOVX - Multiplikator Forward P/S|EDSA (Edesa Biotech, Inc.) - Multiplikator forward rega marang pendapatan|ibioinc.com - Rega forward marang dodolan|CARM (Carisma Therapeutics Inc) - Multiplikator Forward P/S|XTL Biopharmaceuticals Ltd (XTLB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics (BOLT)|Multiplikator forward rega marang pendapatan hcwbiologics.com HCWB|Rasio rega marang prakiraan pendapatan Aptevo Therapeutics Inc. APVO|AIM - Multiplikator forward rega marang pendapatan|ADTX: Multiplikator forward rega marang pendapatan|GRI - Multiplikator Forward P/S|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan HIND|REVB (Revelation Biosciences) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep indaptusrx.com INDP|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI (calcimedica.com) - Rega forward marang dodolan|Multiplikator Forward P/S AFMD (Affimed N.V.)|Rasio kapitalisasi marang dodolan sing dikarepake Allakos Inc (ALLK)|HOOKIPA - Multiplikator Forward P/S|Prakiraan rega marang pendapatan IGM Biosciences, Inc. (IGMS)|ITOS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ocean Biomedical Inc (OCEA)|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Rasio rega marang prakiraan pendapatan THRD
